Outcome of patients with multiple myeloma and hypertension
treated with angiotensin-I-converting enzyme inhibitors during
high-dose chemotherapy.

J 2005

Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy.

BÜCHLER, Tomáš, Marta KREJČÍ, A. SVOBODNÍK, Zdeněk ADAM, J. MINAŘÍK et. al.

Základní údaje

Originální název

Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy.

Název česky

Léčba hypertenze pomocí ACE-1 u pacientů s MM při vysokodávkované chemoterapii

Autoři

BÜCHLER, Tomáš (703 Slovensko), Marta KREJČÍ (203 Česká republika), A. SVOBODNÍK (203 Česká republika), Zdeněk ADAM (203 Česká republika), J. MINAŘÍK (203 Česká republika), J. BAČOVSKÝ (203 Česká republika), V. ŠČUDLA (203 Česká republika), Jiří MAYER (203 Česká republika), Jiří VORLÍČEK (203 Česká republika) a Roman HÁJEK (203 Česká republika, garant)

Vydání

The hematology journal, England, Nature Publishing Group, 2005, 1466-4860

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14110/05:00035895

Organizační jednotka

Lékařská fakulta

UT WoS

000227444300002

Klíčová slova česky

mnohočetný myelom; hypertenze; ACE-1

Klíčová slova anglicky

multiple myeloma; hypertension; angiotensin-1-converting enzyme

Štítky

angiotensin-1-converting enzyme, Hypertension, multiple myeloma

Změněno: 23. 6. 2009 10:13, Mgr. Anna Potáčová, Ph.D.

Anotace

ORIG CZ

V originále

In a retrospective study we have sought to determine whether the administration of angiotensin-I-converting enzyme inhibitors (ACEI) influences the outcome of patients with multiple myeloma (MM). Patients with MM who underwent autologous peripheral blood stem cell transplantation (PBSCT) (n=168) were studied. Patients taking ACEI alone or in combination with other antihypertensive agents during the hospital admission for PBSCT were allocated to the ACEI group (n=25; 15%). In conclusion, according to our findings, ACEI administered during PBSCT have adverse effect on survival of patients with MM.

Česky

V publikaci je popsán vliv angiotenzin-1 konvertujícího enzymu na pacienty s MM po transplantaci.

Citovat

BÜCHLER, Tomáš, Marta KREJČÍ, A. SVOBODNÍK, Zdeněk ADAM, J. MINAŘÍK, J. BAČOVSKÝ, V. ŠČUDLA, Jiří MAYER, Jiří VORLÍČEK a Roman HÁJEK. Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy. The hematology journal. England: Nature Publishing Group, 2005, roč. 5, č. 7, s. 559-564. ISSN 1466-4860.

@article{837912,
   author = {Büchler, Tomáš and Krejčí, Marta and Svobodník, A. and Adam, Zdeněk and Minařík, J. and Bačovský, J. and Ščudla, V. and Mayer, Jiří and Vorlíček, Jiří and Hájek, Roman},
   article_location = {England},
   article_number = {7},
   keywords = {multiple myeloma; hypertension; angiotensin-1-converting enzyme},
   language = {eng},
   issn = {1466-4860},
   journal = {The hematology journal},
   title = {Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy.},
   volume = {5},
   year = {2005}
}

TY  - JOUR
ID  - 837912
AU  - Büchler, Tomáš - Krejčí, Marta - Svobodník, A. - Adam, Zdeněk - Minařík, J. - Bačovský, J. - Ščudla, V. - Mayer, Jiří - Vorlíček, Jiří - Hájek, Roman
PY  - 2005
TI  - Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy.
JF  - The hematology journal
VL  - 5
IS  - 7
SP  - 559-564
EP  - 559-564
PB  - Nature Publishing Group
SN  - 14664860
KW  - multiple myeloma
KW  - hypertension
KW  - angiotensin-1-converting enzyme
N2  - In a retrospective study we have sought to determine whether the administration of angiotensin-I-converting enzyme inhibitors (ACEI) influences the outcome of patients with multiple myeloma (MM). Patients with MM who underwent autologous peripheral blood stem cell transplantation (PBSCT) (n=168) were studied. Patients taking ACEI alone or in combination with other antihypertensive agents during the hospital admission for PBSCT were allocated to the ACEI group (n=25; 15%). In conclusion, according to our findings, ACEI administered during PBSCT have adverse effect on survival of patients with MM.
ER  -

BÜCHLER, Tomáš, Marta KREJČÍ, A. SVOBODNÍK, Zdeněk ADAM, J. MINAŘÍK, J. BAČOVSKÝ, V. ŠČUDLA, Jiří MAYER, Jiří VORLÍČEK a Roman HÁJEK. Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy. \textit{The hematology journal}. England: Nature Publishing Group, 2005, roč.~5, č.~7, s.~559-564. ISSN~1466-4860.

Podrobný výpis o publikaci